Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 298–298 | Cite as

Pembrolizumab

Hyperprogression of lung adenocarcinoma: case report
Case report
  • 12 Downloads

Reference

  1. Tanaka Y, et al. Hyperprogressive disease after treatment with pembrolizumab in lung adenocarcinoma: An autopsy case study. Respiratory Medicine Case Reports 28: 100885, 2019. Available from: URL: https://doi.org/10.1016/j.rmcr.2019.100885 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations